MYC and cancer: Disruption of the molecular circadian clock is a common feature of MYC amplification across several kinds of cancer, so it stands to reason that inhibition of MYC in cancer may re-activate the molecular clock, or more precisely, allow the molecular clock of cancer cells to again respond to external entrainment signals.